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Background: Effective use of contraception can reduce numbers of unintended pregnancies, but
misunderstandings and concerns about contraception abound. Increasingly, women seek health-care
information online.
Objectives: To develop an interactive website to aid informed choice of contraceptive method, including
long-acting reversible contraception (Phase I), and test its effectiveness in a parallel, single-blind
randomised trial (Phase II). Approval came from London – Camden & King’s Cross Research Ethics
Committee (reference 17/LO/0112).
Setting and participants: For both phases, women aged 15–30 years were recruited from general
practice, sexual health services, maternity services, community pharmacies and an abortion service.
Design: In Phase I, we conducted three systematic literature reviews, a review of YouTube (YouTube,
LLC, San Bruno, CA, USA) videos about contraception, and focus groups and interviews with young
women to explore barriers to and concerns and misperceptions about contraception. We then iteratively
co-designed an interactive website, Contraception Choices [URL: www.contraceptionchoices.org
(accessed June 2020)], with young women and a software company. In Phase II, we evaluated the
website through a randomised trial that began as a feasibility trial. Early demand for Contraception
Choices stimulated a design change from a feasibility to an efficacy trial, with follow-up for clinical
outcomes at 3 and 6 months. A randomisation list was incorporated into the trial software program to
allocate participants to the intervention (website) or control group (standard care).
Intervention: Contraception Choices is a co-designed, evidence-based, interactive website to aid informed
choice of contraception. It provides information about different methods, addresses common concerns and
offers tailored contraceptive options in response to individual preferences.
DOI: 10.3310/hta24560 Health Technology Assessment 2020 Vol. 24 No. 56
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Stephenson et al. under the terms of a commissioning contract issued by the Secretary of
State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be
included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for
commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha
House, University of Southampton Science Park, Southampton SO16 7NS, UK.
v
Main outcome measures: Qualitative – participant views and experience of the intervention, assessed
through qualitative interviews. Quantitative primary outcomes – follow-up rate at 6 months in the
initial feasibility trial, using a long-acting reversible contraception method, and satisfaction with
contraceptive method at 6 months in the efficacy trial.
Results: A total of 927 women were randomised online to the website (n = 464) or control group
(n = 463), of whom 739 (80%) provided follow-up data at 6 months [786 women (85%) provided
data at 3 and/or 6 months that were included in the analysis of primary outcomes]. There was little
difference between groups in the proportion using long-acting reversible contraception at 6 months
[30.4% intervention vs. 31.0% control, adjusted odds ratio after imputation 0.87 (95% confidence
interval 0.60 to 1.27)] or in satisfaction with contraceptive method [proportion being ‘satisfied’ or
‘very satisfied’, 82.6% intervention vs. 82.1% control, adjusted odds ratio 0.93 (95% confidence interval
0.69 to 1.25)]. Qualitative evaluation indicated highly positive views about the website and increased
knowledge of contraceptive methods that could dispel misperceptions. Women appreciated having
information tailored to their specific needs and felt better prepared before consultations.
Limitations: We did not include intermediate measures, such as knowledge of contraceptive methods,
intention to change method or confidence in discussing contraception with a health-care professional,
which may have indicated other benefits of using the website. In future, the website should be studied
in different settings (e.g. schools and in routine practice) to see whether or not it improves the quality
or efficiency of contraceptive consultations.
Conclusions: Our systematic review indicated wide-ranging influences on women’s use of contraception
globally. The website, Contraception Choices, was very popular with young women and contraception
service providers. It was not associated with statistically significant differences in use of long-acting
reversible contraception or satisfaction with contraceptive method at 6 months.
Trial registration: Current Controlled Trials ISRCTN13247829.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health
Technology Assessment programme and will be published in full in Health Technology Assessment;
Vol. 24, No. 56. See the NIHR Journals Library website for further project information.
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What was the question?
Choosing between types of contraception can be challenging, so can a website help women make the
right choice for them?
What did we do?
We asked women what they think about contraception. We looked at other studies and YouTube
(YouTube, LLC, San Bruno, CA, USA) videos. We then designed the Contraception Choices website with
young women [URL: www.contraceptionchoices.org (accessed January 2020)].
The website describes each type of contraception and compares them side by side. When users answer
questions about what matters to them, the website suggests three types of contraception they might
like. A total of 927 women helped us test the website in an online trial. We asked everyone what
contraception they were using and how satisfied they were with it 6 months later.
What did we find?
Women really liked the website. Ninety-seven per cent of participants found it helpful or very helpful
for ‘getting useful information about contraception’ and 87% responded that it was helpful or very
helpful for ‘finding a method of contraception that is right for you’. Comments included:
I feel very well educated thanks to the website – I wish someone had explained about all the different
choices years ago.
It’s cleared up some of my doubts and things I worried about (probably unconsciously!) about
hormonal contraception.
However, seeing the website did not mean that women used a more reliable type of contraception.
Women were just as satisfied with their contraception whether or not they had seen the website.
We think that this is because many other factors are involved; for example, some women found it
difficult to access long-acting contraception methods from health services.
What does this mean?
Young women liked the Contraception Choices website and found it useful. Women can be put
off by contraception side effects and the views of partners, friends, family and others. On its own,
the Contraception Choices website was not enough to help more women use the most reliable
contraception methods.
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Control of fertility is crucial to the health and well-being of women, but unintended pregnancy remains
common and costly for both health services and individuals. In the UK, despite a range of freely available
effective contraceptive methods, abortion rates have changed little over two decades (at around 190,000
per year for women resident in England and Wales).
Preventing unintended pregnancy involves many processes, including timely education, awareness and
socially patterned behaviours, that lead women to seek, choose and use contraception consistently and
correctly. Health services have a key role to play by supporting women to choose and use an appropriate
method that best meets their needs, but many women are still not aware of the range of methods available
to them. The combined oral contraceptive pill and condoms are well known and widely used, but are not
the most effective contraceptive methods. Long-acting reversible contraception, that is intrauterine devices,
intrauterine systems, implants and injections, is over 20 times more effective than oral contraceptives and
condoms, but these methods are less well known to women and may not even be discussed in settings
without the capacity to provide them.
Increasingly, women turn to online sources of information on health care. However, online information
is of variable quality and misperceptions about contraception are common. This study aimed to develop
and test the effectiveness of an interactive website to aid informed choice of contraceptive method.
Phase I objectives
1. To systematically review evidence on individual-level education or decision aid interventions
relating to acceptability and uptake of and adherence to contraception (including underpinning
theories, and user and provider views).
2. To obtain the views of contraceptive service users and providers in five settings (general practice,
sexual and reproductive health services, abortion services, maternity services and community
pharmacies), relating to access to and acceptability and uptake of contraception.
3. To apply the information from objectives 1 and 2 to identify the key design issues and content for
an interactive digital intervention or website.
4. To co-design the website with young women and health-care professionals.
Phase II objectives
5. To conduct a randomised feasibility trial of the website in five different service settings (general
practice, sexual and reproductive health services, abortion services, maternity services and
community pharmacies).
6. To assess, through qualitative process evaluation, the acceptability of the trial procedures, women’s
views of the intervention itself and NHS implementation considerations.
7. To write a protocol for a definitive trial of an interactive digital intervention to aid informed choice
of contraception and the acceptability and uptake of and adherence to long-acting reversible
contraception methods in young women.
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In Phase I, we completed three systematic literature reviews, a review of YouTube (YouTube, LLC,
San Bruno, CA, USA) videos and discussion threads about contraception, and conducted focus groups
and interviews with young women to explore barriers, benefits, concerns, myths and misperceptions
relating to contraception. In addition, we sought the views of health professionals and held an expert
workshop. From these findings, we developed a logic model to guide design of a new interactive website:
Contraception Choices [URL: www.contraceptionchoices.org (accessed January 2020)]. The website was
designed through an iterative process of consultation with young women and a commercial software
company. In Phase II, we evaluated the effectiveness of the website in an individually randomised trial
using qualitative and quantitative methods.
Recruitment and trial methodology
For both phases, women aged 15–30 years were recruited from clinical sites representing the settings
in which the great majority of contraceptive consultations occur: a general practice (Clerkenwell,
North East London), sexual health services (Brook, Euston and the Margaret Pyke Centre), a maternity
service (Ashford and St Peter’s Hospitals NHS Foundation Trust), a community pharmacy (Green Light
Pharmacy London) and an abortion service (British Pregnancy Advisory Service, East London).
In the feasibility trial, women were recruited in clinic by a researcher using a tablet computer. The trial
software was designed to enable participants to go through the steps of screening, consent, automatic
randomisation, data collection and website viewing without assistance, although in practice this process
was nearly always supported by a researcher. Participants allocated to the intervention condition were
immediately directed to the Contraception Choices website. Those allocated to the control condition
were invited to view the website at the end of the trial in 6 months’ time. All participants were followed
up by e-mail, text or mobile phone at 3 and 6 months, and asked to complete an online questionnaire for
outcome data. Free-text comments from the questionnaire were used for qualitative analysis.
The popularity of the Contraception Choices website among young women and the demand from
contraception providers to disseminate the website led to the feasibility trial becoming a Phase III,
or efficacy, trial. To achieve this, we increased the recruitment target – from 400 in the feasibility trial
to 930 in the efficacy trial – and changed the primary outcome from a feasibility measure (6-month
follow-up rate) to clinical outcomes that were originally secondary outcomes in the feasibility trial.
This resulted in two primary outcomes for the efficacy trial: use of long-acting reversible contraception
at 6 months and satisfaction with contraceptive method at 6 months. A sample size of 930 was
estimated to be sufficient to detect (with 82% power) an increase in uptake of long-acting methods
from 35% to 47%, assuming a follow-up rate of 70%. We also conducted a budget impact analysis
of the website and contraception, reporting the total costs to each payer [NHS (primary care vs.
secondary care), local government, private and out of pocket] and the total cost of contraception and
pregnancy outcomes for a range of population sizes.
Rapid expansion in recruitment was achieved by recruiting women online (rather than in clinic)
from one of the study sites, the Margaret Pyke Centre. When women request an appointment for
contraception at this clinic, they are routinely directed to the trust website to book their appointment.
Once an appointment is booked, the patient receives a text message confirming the date and time of
the clinic appointment. For the trial, we inserted into the routine text an invitation to take part in
contraception research by clicking on a hyperlink, which took women to the trial recruitment home
page. From this point, the trial procedures were the same as for women recruited in clinic.
In effect, by changing from a feasibility trial to an efficacy trial, we completed the trial referred to in
objective 7 (see Phase II objectives) rather than writing a protocol for it.
SCIENTIFIC SUMMARY
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Results from Phase I
Review of published literature
Our meta-synthesis of 18 systematic reviews of factors affecting choice and use of contraception
showed that pathways to successful contraception choice and use are complex and strongly shaped
by factors that are often outside the control of individual women. Globally, use of contraception is
influenced by the perceived likelihood and appeal of pregnancy, relationship status, knowledge, beliefs,
and perceptions of side effects and health risks. Male partners have a strong influence on contraception
uptake, as do the views and experiences of peers, and family members’ expectations. Lack of education
and poverty are linked with low contraception use, and social and cultural norms influence expectations
of family size and timing. Contraception use also depends on the availability of methods, the accessibility,
confidentiality and costs of health services, and attitudes, behaviour and skills of health-care personnel.
Our second systematic review of trials of interactive digital interventions for contraception choice and
use found one significantly positive trial and showed that digital interventions for contraception are
feasible and promising, and that offering access in clinic waiting rooms is appropriate.
Our third review of 21 systematic reviews of face-to-face interventions for contraception and theories
about contraception decision-making included a meta-analysis of eight randomised controlled trials
(which found that motivational interviewing significantly increased effective use of contraception) and
a synthesis of eight trials of educational interventions (which found educational interventions to be
effective for knowledge acquisition, but not for change in attitudes or behaviour). Goal-setting and
self-monitoring are important elements of many successful interventions.
Women’s views: qualitative fieldwork
Qualitative data, from focus groups, interviews with 74 women and review of 35 YouTube videos
and discussion threads, were coded and categorised by theme and subtheme. The key findings can be
summarised as follows:
l The most commonly expressed concern about contraception was the ‘unnaturalness’ of hormones
contained in hormonal contraceptive methods.
l Other commonly expressed concerns or anxiety about contraception related to infertility, irregular
bleeding, having no periods, risk of cancer and side effects.
l Many women think it is unhealthy to skip periods.
l Many women think their bodies need a break from contraception.
l Women do not have a good understanding of contraceptive side effects.
l There is a strong tendency to underestimate contraceptive benefits and to overestimate
contraceptive side effects.
l Partners’ views are important to women.
l Women like seeing honest videos of other women talking about their experiences of contraception.
l Women dislike seeing a lot of text on a website and would prefer to have options to view more
information if they wish to know more.
Views of health-care providers
The interviews with health-care professionals gave rise to all the same issues raised by women
themselves in relation to contraceptive knowledge, concerns and misperceptions. Other issues explored
in interviews with health-care professionals were practical ones relating to the feasibility trial design
and the practicalities of recruiting in clinics, such as access to Wi-Fi.
The Contraception Choices website draws on all these findings to provide information that addresses
women’s concerns about and barriers to uptake of contraception, including, for example, a dynamic
infographic to compare the effectiveness of different methods. Young women’s perspectives and
concerns are integral to the design and content, which acknowledge explicitly the challenges that
DOI: 10.3310/hta24560 Health Technology Assessment 2020 Vol. 24 No. 56
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Stephenson et al. under the terms of a commissioning contract issued by the Secretary of
State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be
included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for
commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha
House, University of Southampton Science Park, Southampton SO16 7NS, UK.
xix
women often face, and offer straightforward advice in a way that does not judge women for their
choices or situations. A key feature is an interactive decision tool that takes the user through a series
of questions designed to identify appropriate method(s) that best suit individual preferences (e.g. for a
non-hormonal method, one that does not require insertion by a health-care professional or one that is
invisible), and then generates three suitable contraceptive options, with brief annotation. The three
options can then be sent by e-mail or text to a mobile for further personal consideration, discussion
with friends and family or discussion during a contraceptive consultation (although contraceptive
consultations were not assessed in the trial).
Results from Phase II: randomised trial
Quantitative and qualitative findings
The first participant was randomised on 4 July 2017 and the last on 22 December 2017. The first
woman was recruited through the online central booking service on 31 October 2017 and the last
on 22 December 2017. Recruitment online was much faster than in the clinics. It took approximately
6 months to recruit 400 women from the clinic sites, as originally planned (we recruited 530 women
via the online booking system in just over 7 weeks).
Two-thirds of participants were from white ethnic groups, half were educated to degree level and
four-fifths reported English as their first language. Ten per cent were pregnant, whereas 90% indicated
a current need for contraception to avoid unintended pregnancy. The most common method at baseline
was the pill, followed by long-acting reversible contraception methods. Around two-thirds of women
were satisfied with their current method at baseline.
In total, 927 women were randomised to the website group (n = 464) or to the control group (n = 463),
of whom 739 (80%) provided follow-up data at 6 months. A total of 786 women (86%) provided data
at 3 or 6 months, or at both time points, and were included in the analysis of primary outcomes
with imputation. Written feedback about the website was provided by more than four-fifths of trial
participants in the intervention group. The main themes were about the website information and
content, the design and format, interaction with health professionals, being part of the study and a
range of impacts of the website. The last theme included switching to another method, changing
behaviour as a result of correcting a misperception about contraception, personal sexual responsibility,
discussing the website with others and barriers to accessing contraception. Apart from barriers to
access, comments were strikingly positive and appeared to affirm the purpose of the website.
Across both study arms, satisfaction with method of contraception improved from around two-thirds at
baseline to four-fifths at follow-up. There was no statistically significant difference between intervention
and control groups in the proportion of women using long-acting reversible contraception at 6 months
[30.4% intervention vs. 31.0% control, adjusted odds ratio after imputation 0.87 (95% confidence
interval 0.60 to 1.27)], nor in level of satisfaction with contraceptive method [proportion being ‘satisfied’
or ‘very satisfied’, 82.6% intervention vs. 82.1% control, adjusted ordinal odds ratio 0.93 (95% confidence
interval 0.69 to 1.26) based on the five ordered responses]. In the budget impact analysis, there was
no statistically significant difference between the two groups in publicly funded contraception costs
excluding pregnancy (£3.67, 95% confidence interval –£18.17 to £28.56) or including pregnancy (£73.65,
95% confidence interval –£46.38 to £192.40) or private out-of-pocket costs (£11.19, 95% confidence
interval –£2.84 to £26.72).
Conclusions
The Contraception Choices website was popular among young women because of its design,
presentation of trustworthy information and guidance in choosing a method tailored to individual
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preferences. However, it was not associated with any statistically significant difference in use of long-
acting reversible contraception or satisfaction with contraceptive method at 6 months. Our systematic
reviews confirmed multiple factors affecting women’s choice and use of contraception, which go beyond
informed choice. The lack of effect on clinical outcomes in this trial, despite highly positive feedback
from participants, highlights a gap between improving delivery of personalised information and impact
on contraceptive use. We hypothesise that this gap can be narrowed by shared reference to the website
between patients and health-care professionals during contraception consultations. Contraception
providers are keen to promote the website. The priority for further research is to determine whether
or not use of the website during contraceptive consultations improves the quality of consultation and
thereby clinical or service outcomes, ideally over a follow-up period of at least 1 year.
Trial registration
This trial is registered as ISRCTN13247829.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 56.
See the NIHR Journals Library website for further project information.
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Control of fertility is crucial to the health and well-being of women, but unintended pregnancyremains common and costly for both health services and individuals. In the UK, despite a range of
freely available effective contraceptive methods, abortion rates have changed little over two decades
(at around 190,000 per year for women resident in England and Wales).1 Despite a national teenage
pregnancy strategy and recent fall in conceptions among those aged < 18 years, England still has the
highest rate of teenage pregnancy in western Europe. A key report on the economics of sexual health
concluded that it should be feasible to improve contraception and abortion services in ways that better
meet the preferences of service users and that this could lead to a net saving (largely from fewer
unintended pregnancies and reduced delay in abortion) of up to £1B over 15 years.2
Although avoidance of unintended pregnancy may be viewed as a shared responsibility between sexual
partners, the burden of decision and action more often remains with women. Preventing unintended
pregnancy involves many processes, including timely education, awareness and socially patterned
behaviours that lead women to seek, choose and use contraception consistently and correctly. Health
services have a key role in supporting women to choose and use an appropriate method that best
meets their needs. However, many women are still not aware of the range of different methods
available to them. There are widespread myths about contraception (e.g. fears about impact on future
fertility, weight gain or the significance of amenorrhoea). The combined oral contraceptive pill and
condoms are well known and widely used – by around half of all women using contraception – but
they are not the most effective contraceptive methods.
Long-acting reversible contraception (LARC) methods, including copper intrauterine devices,
progestogen-only intrauterine systems, progestogen-only injectable contraceptives and progestogen-only
subdermal implants, offer women the most effective protection against pregnancy. Women who use
oral contraceptive pills, the contraceptive patch or vaginal ring have a 20 times higher failure rate
than women who use LARC methods.3 More than a decade ago, the National Institute for Health and
Care Excellence (NICE) concluded that increasing uptake of LARC is more cost-effective in reducing
unintended pregnancy than the contraceptive pill or condoms, even at 1 year.4 At that time (2005),
estimated uptake of LARC in the UK was low, at 8% (2003/4 data), compared with 25% for the oral
contraceptive pill and 23% for male condoms. Since then, uptake of LARC has increased, to 12% in
the population in 2008/9 and to 41% by 2013, in women attending community contraceptive clinics.5
Even in specialist community services, younger women are less likely to use LARC (24% in those aged
< 30 years) than older women.
There are multiple pathways by which women get information about contraception and choose a
method. The main sources of information are the internet, family and friends, school relationships and
sex education, general practitioners (GPs), community pharmacies, and sexual and reproductive health
services. However, not all of these sources provide information on LARC and uptake of LARC is limited
by the number of appropriately trained doctors or nurses to fit them. It is understood that many
general practices, which are the source most commonly used by women for contraception,6 have little
or no capacity for fitting and therefore rely on referral to specialist contraceptive services. Effective
interventions are needed that expand women’s choice of more effective methods of contraception,
and increase uptake in a variety of settings.
Current standard care pathways for contraception vary considerably within and between different
settings. Some services provide leaflets (e.g. the Family Planning Association) explaining the different
methods, but the extent to which such leaflets are read, understood or help women reach an informed
decision about contraceptive method is unclear. The quality of face-to-face consultation varies widely
between different health-care providers with different skills, competencies and experience. The
evidence base for improving contraceptive uptake and adherence through better face-to-face
DOI: 10.3310/hta24560 Health Technology Assessment 2020 Vol. 24 No. 56
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Stephenson et al. under the terms of a commissioning contract issued by the Secretary of
State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be
included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for
commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha
House, University of Southampton Science Park, Southampton SO16 7NS, UK.
1
consultations is slim and mostly disappointing;7–9 our population-based study (funded by the UK
Medical Research Council) of why women stop or switch contraceptive methods concluded that
traditional consultation with a doctor or nurse in clinic has only modest influence on women’s
contraceptive decisions.
Health care in the UK is undergoing a health informatics revolution. The vast majority of young people
have access to digital technology, which offers huge potential for health promotion. Recent data from
the Office for National Statistics indicate that 99% of 16- to 24-year-olds have accessed the internet
and 88% use it daily.10 We know that younger women are likely to turn to digital resources for
information on contraception.11 For the proposed study, we therefore explored the use of interactive
digital interventions (IDIs) that provide information and decision support for contraceptive choices.12–15
IDIs may be available directly to users for self-guided use, or available with remote or face-to-face
human support. They may be delivered by any digital medium, including the internet, mobile phone
and handheld computers. Access can be private and self-paced, and programmes can be tailored
according to individual characteristics. Digital interventions are effective at increasing knowledge of
emergency contraception16 and there is evidence of effect on sexual behaviour,12 contraceptive choice
and adherence.13–15 However, we are not aware of any services in the UK that currently provide IDIs
to support women’s contraceptive decision-making.
Study aims and objectives
The original aim of the study was to develop (Phase I) and test the feasibility (Phase II) of an
intervention to increase the uptake of LARC methods in young women. LARC methods include
intrauterine devices, intrauterine systems, subdermal implants and injectable contraception.
Phase I objectives
1. To systematically review evidence on individual-level education or decision aid interventions
relating to acceptability, uptake and adherence to LARC, including underpinning theories and user
and provider views [see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed
January 2020)].
2. To obtain the views of contraceptive service users and providers in five settings (general practice,
sexual and reproductive health services, abortion services, maternity services and community
pharmacies) relating to access, acceptability and uptake of LARC.
3. To apply the information from objectives 1 and 2 to identify the key design issues and content for
an IDI.
4. To co-design the IDI with young women and health-care professionals.
Phase II objectives (including transition from a feasibility trial to an efficacy trial)
The original objectives were:
5. To conduct a randomised feasibility trial of the IDI in five different service settings (general
practice, sexual and reproductive health services, abortion services, maternity services and
community pharmacies).
6. To assess, through qualitative process evaluation, the acceptability of the trial procedures, women’s
views of the intervention itself and NHS implementation considerations.
7. To write a protocol for a definitive trial of an IDI to improve informed choice of contraception and
the acceptability, uptake and adherence to LARC methods in young women.
However, when we presented the website at conferences and seminars, the response from colleagues
working in sexual and reproductive health was overwhelmingly positive. Service providers wanted to
direct clients to the Contraception Choices website right away. The immediate demand for the website
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convinced us that definitive testing in a subsequent efficacy trial, which would take years to complete,
would be unwise and arguably unethical. Moreover, one site [the Margaret Pyke Centre (MPC)] wanted
to promote the Contraception Choices website through its routine online system for booking clinic
appointments. In response to this situation, we revised the feasibility trial protocol into an efficacy
(Phase III) trial to examine the effect of the intervention on two clinical outcomes that were originally
secondary outcomes in the feasibility trial: (1) use of a LARC method of contraception and (2) satisfaction
with method of contraception at 6 months. The expansion in recruitment was achieved rapidly by
recruiting women online (rather than in clinic) via the online booking system of the MPC (see below).
By changing from a feasibility trial to an efficacy trial, we completed the trial referred to in objective 7
[see Phase II objectives (including transition from a feasibility trial to an efficacy trial)], rather than writing a
protocol for it.
Study setting
The five main service providers of contraceptive advice and supplies provide the setting for the study:
general practice, sexual and reproductive health services, community pharmacies, maternity services
and abortion services. Together, these settings provide contraceptive care for the great majority of
women in the UK. They include services that provide care for women at highest risk of unintended
pregnancy (i.e. those who attend abortion services or seek emergency contraception through
community pharmacies). These settings also provide care for different demographic subgroups within
the population. Four out of five women go through childbirth, many of whom will require postpartum
contraception to avoid an unintended pregnancy. Around 60% of women aged 16–44 years in Britain
access contraception through general practice, whereas 23% of women attend community (sexual and
reproductive health) clinics each year for contraception.6
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Chapter 2 Phase I: design and development of
the website
Overview of methods
We conducted three systematic reviews of the literature: (1) a review of reviews of factors influencing
contraception choice and use, (2) a review of IDIs for contraception and (3) a review of face-to-face
interventions for contraception and theoretical approaches to contraception decision-making.
We conducted six focus groups and 25 individual interviews to explore the views of 74 young women
relating to contraception (access, acceptability, barriers and concerns), the design and content of the
IDI (website) that we wished to develop, and their views on a future randomised controlled trial of
such a website. We also reviewed 35 YouTube (YouTube, LLC, San Bruno, CA, USA) videos of women
talking about contraception, including views expressed in video comment threads.
We synthesised the findings from the systematic reviews, women’s views on YouTube and qualitative
research with women and health professionals, and held an expert workshop to develop a trial-ready,
self-guided website that presents a number of contraceptive options in response to input of women’s
preferences and concerns.
Objective 1 (systematic reviews)
Systematic review 1: factors influencing contraception choice, uptake and use –
a meta-synthesis of systematic reviews
We synthesised the findings of 18 systematic reviews that were mostly of moderate or high quality [see
www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed January 2020)]. Factors affecting
contraception use are remarkably similar among women in very different cultures and settings globally.
Use of contraception is influenced by the perceived likelihood and appeal of pregnancy, and relationship
status. Contraception choice and uptake is influenced by women’s knowledge, beliefs and perceptions of
side effects and health risks. Male partners have a strong influence on contraception uptake, as do the
views and experiences of peers, and family members’ expectations. Lack of education and poverty are
linked with low contraception use, and social and cultural norms influence contraception and expectations
of family size and timing. Contraception use also depends on the availability of methods, the accessibility,
confidentiality and costs of health services, and attitudes, behaviour and skills of health-care personnel.
It is clear that contraception has remarkably far-reaching benefits and is highly cost-effective.
However, our synthesis shows that women worldwide lack sufficient knowledge, capability and
opportunity to make reproductive choices, and health-care systems often fail to provide access and
informed choice. Urgent action is needed at many levels, involving a range of stakeholders, to enable
informed family planning choice, and enhance the life chances of women and their families.
Systematic review 2: effectiveness of interactive digital interventions for contraception
choice, uptake and use
We completed a review of IDIs for contraception [see www.journalslibrary.nihr.ac.uk/programmes/hta/
137909/#/ (accessed January 2020)]. Our extensive search using Cochrane Collaboration systematic
review methods found five randomised controlled trials (RCTs) of IDIs for contraception and one
cost-effectiveness analysis. One RCT demonstrated a statistically significant impact of an IDI plus a
tailored printout in comparison with a generic contraception leaflet on uptake of an effective birth
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control method [155/206 (75.2%) vs. 318/490 (64.9%); p = 0.008]. The same trial showed no difference
between tailored and generic printouts of IDI results. It was not possible to combine any of the RCT
results because of the risk of bias, or too few trials in each analytic group. Cost-effectiveness analysis
of a facilitated IDI predicted eight fewer births per 100 women at an unadjusted cost of US$18,672
per prevented repeated birth.
We concluded that IDIs for contraception choice and use are feasible, and one high-quality RCT
demonstrated a statistically significant impact on contraception choice. Access to, and information
about, contraception is crucial to women’s health and well-being. IDI could play an important role in
providing convenient, reliable and tailored information about contraception and support for choice
of method.
Systematic review 3: effectiveness of face-to-face interventions for contraception and
review of theoretical approaches to contraception decision-making
We synthesised the findings of 21 systematic reviews of interventions for contraceptive choice and use.
A meta-analysis of eight RCTs found that motivational interviewing significantly increased effective
contraceptive use up to 4 months post intervention, but without a later reduction in pregnancy.17 A
synthesis of eight trials of educational interventions (including written materials, audiotapes, videotapes,
interactive computer games, contraceptive decision aid and feedback from a provider) found that
they are effective for knowledge acquisition, but not for change in attitudes or behaviour.18 Multiple
interventions (combining educational and contraceptive-promoting interventions) significantly lowered
the risk of unintended pregnancy among adolescents.19
Contraception interventions based on theoretical constructs appear to be more effective than those
not using theory.20 Evidence suggests that the most effective behaviour change interventions are those
that use multiple strategies to achieve multiple goals, including, for example, awareness, information
transmission, skill development and supportive environments. Goal-setting and self-monitoring are
important elements of many successful interventions. Behavioural interventions should be sensitive to
audience and contextual factors, and recognise that most behaviour change is incremental and that
maintenance of change usually requires continued and focused efforts.
Objective 2 (views of contraceptive service users and providers)
Recruitment
We invited young women to share their views on computer-based interventions for sexual health via
focus groups and interviews [see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed
January 2020)]. Before recruiting from the five clinics involved in the project (a community pharmacy,
a general practice, two sexual health centres, an abortion clinic and a maternity clinic), we first piloted
the study materials with women who were students at University College London to make sure that
the questions made sense and to test out the topic guide. Initially, we held a practice focus group
with six students recruited from University College London to test the topic guide, make sure that
women understood the questions and to make sure that the questions were suitable. Following this,
recruitment started in each of the clinic sites. We placed posters [see www.journalslibrary.nihr.ac.uk/
programmes/hta/137909/#/ (accessed January 2020)] in each clinic waiting room and leaflets (reduced-
size poster) were handed out by reception staff and a researcher, inviting women to take part. Eligibility
criteria included being aged 15–30 years, having the ability to converse in English language and give
informed consent, and having an interest in taking part in contraceptive research.
Six focus groups were conducted with 44 women recruited from a sexual health clinic, a general practice
and a pharmacy. In addition, individual interviews were conducted with five women recruited from a
maternity hospital, 12 women from an abortion clinic and eight women from a young person’s sexual
health service. Individual interviews were preferred by women attending these clinics for the following
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reasons: women from the maternity hospital found it inconvenient to return to a focus group, women
from the abortion clinic did not want to be identified in the focus group as having had an abortion and
women recruited from the young person’s service were doubtful about returning for a focus group. The
focus groups were conducted in university offices and the interviews were conducted in private rooms
in each clinic. Each participant received a participant information sheet and provided written consent.
Participants were offered £20 for taking part in the research, as a token of appreciation. Interviews
were audio-recorded and transcribed, with participant permission.
Topic guide
At each interview and focus group, women were made aware of the nature of the research and the
confidentiality of their data. Ground rules for focus groups were also agreed at the outset. Questions
on the topic guide centred around (1) views relating to access, acceptability, uptake and adherence to
contraception; (2) views on proposed research design of a future RCT; and (3) design and content of an
IDI for contraception decision-making [see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/
(accessed January 2020)].
Analysis of qualitative data
Thematic analysis was used to identify patterns and links within the qualitative data. The data were coded
and categorised by theme and relationships between different elements of the text were identified. There
was discussion of the findings and coding decisions within the team. The data set was analysed as a whole,
seeking consistency or contradiction in themes within and across transcripts. Data were interpreted in the
light of the context they were collected.
Key findings
l The most commonly expressed concern about contraception was the ‘unnaturalness’ of hormones
contained in hormonal contraceptive methods.
l Other commonly expressed concerns or anxiety about contraception related to infertility, irregular
bleeding, having no periods, risk of cancer and side effects.
l Many women think that it is unhealthy to skip periods.
l Many women think that their bodies need a break from contraception.
l Women do not have a good understanding of contraceptive side effects.
l There is a strong tendency to underestimate contraceptive benefits and to overestimate
contraceptive side effects.
l Partners’ views are important to women.
l Women like seeing honest videos of other women talking about their experiences of contraception.
l Women dislike seeing a lot of text on a website and would prefer to have options to view more
information if they wish to know more.
Views of health-care providers
Each site had a project lead who was recruited for interview. Other members of staff were recruited
and interviewed on the suggestion of the leads. Fourteen health-care professionals were interviewed in
total: three specialist (sexual and reproductive health) doctors, two GPs, two pharmacists, five nurses,
one midwife and one receptionist. The interviews with health-care professionals gave rise to all the
same issues raised by women themselves in relation to contraceptive knowledge, concerns and
misperceptions. Other issues explored in interviews with health-care professionals were practical ones
relating to the feasibility trial design and the practicalities of recruiting in clinics, such as access to
Wi-Fi [see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed January 2020)].
Objective 2 (review of YouTube videos)
As noted in Chapter 1, women increasingly turn to digital sources for information on health care, and
contraception is no exception. The social media platform YouTube provides a source of ‘raw’ opinions
that can include misperceptions about contraception. We therefore examined the views and concerns
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expressed by women on YouTube in order to identify common misperceptions that would need to be
addressed through the Contraception Choices website.
A qualitative thematic analysis was conducted on contraceptive myths and misperceptions of 35
YouTube video clips and the video comment threads. The search terms used to locate videos were
‘birth control story’, ‘birth control experience’, ‘contraception story’, ‘contraception experience’,
‘contraceptive pill’, ‘hormonal pill’, ‘combined pill’, ‘intrauterine device’, ‘IUD’, ‘intrauterine system’, ‘IUS’,
‘patch’, ‘birth control patch’, ‘contraceptive patch’, ‘depo injection’, ‘depo-provera’, ‘implant’, ‘contraceptive
implant’, ‘nuvaring’ and ‘natural family planning’. Thirty-five video clips matched the search terms; these
had been posted up to a maximum of 5 years before carrying out this analysis (i.e. from November
2010 onwards) and all comments used for analysis had been posted within the last 24 months (i.e.
from November 2013 onwards). Data analysis was completed once data saturation was reached.
The most common myths and misperceptions featured on YouTube included a fear of hormones,
weight gain, needing a break from contraception, cancer, infertility, whether or not contraception
causes moodiness and whether or not it is natural to have periods. Analysis of comments also revealed
women’s concerns about what happens during appointments with clinicians, their fear of asking
questions that might be considered ‘stupid’ and men’s views with regard to women’s contraceptive
choices, which are rarely discussed in the published literature.
Objective 3 (applying the information from objectives 1 and 2 to identify
the key design issues and content for an interactive website)
Website aims
The Contraception Choices website is designed to help women (and male partners) decide which
method of contraception might suit them best, aiming to increase women’s satisfaction with choice of
contraception and to encourage uptake of more effective contraceptive methods. The website aims to
facilitate informed decision-making, which was conceptualised as a voluntary, well-considered decision
that an individual makes on the basis of information and understanding about the advantages and
disadvantages of possible courses of action, made in accordance with the individual’s beliefs.21 Enacting
a decision for contraception use will depend on factors outside women’s control (e.g. access to health
care, availability of a chosen method, and attitudes of partners and others).
Contraception Choices takes as a starting point the concerns that influence women’s choices, and
aims to provide honest information on the advantages and disadvantages of a range of contraception
methods, featuring a decision-making tool from which tailored suggestions are presented, based on
individual users’ priorities and preferences.
Guiding principles underpinning the Contraception Choices website
The website content is written from a sexual and reproductive rights perspective (i.e. people
have a right to honest, straightforward information and freedom of choice regarding contraception,
reproductive decisions and sexual well-being). The team believe that it is a woman’s choice if and when
they get pregnant (acknowledging that there are many influences on this choice, including partners,
family, community and religion). We also believe that it is up to women to decide which method of
contraception suits them, and that health professionals’ role is to facilitate an informed choice without
pressure or judgement.22
Understanding the context and complexity of contraceptive decision-making
To understand the context and complexity of contraception decisions, we conducted systematic
literature reviews, carried out qualitative fieldwork with the target website user group (women aged
15–30 years) and held an expert (health professional) website content workshop. The whole process is
described in the following sections.
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Literature review 1: factors influencing contraception choice, uptake and use
Findings
We synthesised the findings of 18 systematic reviews, which showed that pathways to successful
contraception choice and use are complex, and strongly shaped by factors that are often outside
individual women’s control. Use of contraception is influenced by the perceived likelihood and appeal
of pregnancy, relationship status, knowledge, beliefs, and perceptions of side effects and health risks.
Male partners have a strong influence on contraception uptake, as do the views and experiences of peers
and family members’ expectations. Lack of education and poverty are linked with low contraception use,
and social and cultural norms influence expectations of family size and timing. Contraception use also
depends on the availability of methods, the accessibility, confidentiality and costs of health services, and
attitudes, behaviour and skills of health-care personnel.
Implications for Contraception Choices website design
The website addresses women’s concerns in several different ways: succinct text (‘Contraceptive
Methods’), question and answer format (‘Frequently Asked Questions’), videos (‘Video’) and an
interactive decision aid (‘What’s Right for Me?’). Most of the content addresses women’s concerns and
priorities, rather than the wider influences on women’s decisions. However, a section for male partners
addresses men’s concerns about women’s use of contraception (‘Did you Know? For Men’). Two
infographics acknowledge the complexity of factors that influence contraception choice, including
method benefits and side effects, women’s priorities, partner views, friends, family, the media, wider
society and experiences with health-care professionals (‘Challenges’ and ‘What Matters to Women?’).
Literature review 2: effectiveness of interactive digital interventions for
contraception choice, uptake and use
Findings
We located five RCTs and one health economic analysis of IDI for contraception choice.13–15,23–25 One
RCT13 demonstrated a statistically significant impact of an IDI plus a tailored printout on uptake of an
effective birth control method and another26 showed a statistically significant impact in preventing
unintended pregnancy. The other trials were small and of low quality.
Implications for Contraception Choices website design
This review shows that digital interventions for contraception are feasible and promising, and that
offering access in the waiting rooms of health-care facilities is appropriate. We incorporated a feature
on the Contraception Choices website that allows users to export the personalised results of the
What’s Right for Me? decision tool via e-mail or text message for later reference.
Literature review 3: effectiveness of face-to-face interventions for contraception
and review of theoretical approaches to contraception decision-making
Findings
We synthesised the findings of 21 systematic reviews of interventions for contraceptive choice and use.
A meta-analysis of eight RCTs found that motivational interviewing significantly increased effective
contraceptive use up to 4 months post intervention, but without a later reduction in pregnancy.17 A
synthesis of eight trials of educational interventions (including written materials, audiotapes, videotapes,
interactive computer games, contraceptive decision aid and feedback from a provider) found that they
are effective for knowledge acquisition, but not for change in attitudes or behaviour.18 Multiple
interventions (combining educational and contraceptive-promoting interventions) significantly lowered
the risk of unintended pregnancy among adolescents.19
Contraception interventions based on theoretical constructs appear to be more effective than those
not using theory.20 Evidence suggests that the most effective behaviour change interventions are those
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that use multiple strategies to achieve multiple goals, including, for example, awareness, information
transmission, skill development and supportive environments. Goal-setting and self-monitoring are
important elements of many successful interventions. Behavioural interventions should be sensitive to
audience and contextual factors, and recognise that most behaviour change is incremental and that
maintenance of change usually requires continued and focused efforts.
Implications for Contraception Choices website design
The website content draws on several different theoretical models to prompt active, informed choice
of contraceptive method (see Table 1). A key feature of motivational interviewing is that counselling
starts with people’s own perspectives and seeks to help people find their own motivations for change.
Young women’s perspectives and concerns are integral to the Contraception Choices website design
and content, and advice is offered in a way that does not judge or blame women for their choices or
situations.
Qualitative fieldwork
As described above, our qualitative fieldwork focused on exploring women’s views and experiences of
contraception, to understand their concerns, beliefs, myths and misperceptions, and views on how to
harness the potential benefits of different contraceptive methods. We conducted interviews and focus
groups with 74 young women and reviewed 35 YouTube videos and discussion threads (see Key findings).
Implications for Contraception Choices website design
All of these themes were reflected in the website content and design, addressing women’s beliefs,
concerns, myths, misperceptions, contraception benefits and women’s views on design options,
including section titles, colours, logo and interactive features. The website offers information using
written, video-recorded and pictorial methods (including infographics) to address different preferences
for communication of information and literacy. Text was presented in small chunks wherever possible
(e.g. bullet points), with more information available as wanted.
Hypothesised mechanisms of change
The main issue addressed by the website is the risk of unwanted or unplanned pregnancy. Our logic
model shows how the website content addresses factors that contribute to this, including a lack of
accurate knowledge on contraceptive method choices; worry about side effects or harms; misperceptions
about methods and their use; and little knowledge of or faith in the potential benefits of contraception
[see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed January 2020)]. The website
aims to present relevant information; to address worry about procedures or side effects; to facilitate
women’s ability to weigh up pros and cons of different methods (or no method); and to increase
motivation to find (and obtain) a suitable method.
A key step in obtaining most contraception methods is to consult a health-care professional (either in
person or online). The website exports a record of the three personal contraceptive method suggestions
by e-mail or by text message to users’ mobile phones, if wanted. This is to facilitate recall and can be used
as a prompt for conversations with clinicians. It was hypothesised that interaction with the Contraception
Choices website before a clinical encounter could result in more informed discussions with clinicians, and
shared decision-making, leading to contraception choices that are more likely to be effective and more
likely to be satisfactory (if women are more actively involved in making choices). The website offers a
clinic finder.
Objective 4 (co-developing the website with young women and professionals)
Expert (health professional) intervention content workshop
We held an expert workshop, inviting sexual health clinicians, researchers and e-health experts to
contribute their views on the design of an IDI to help young women make contraceptive choices.
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Participants, who included Contraception Choices research team members and other experts in the
field, were asked to propose and debate design features of a digital intervention, to try to reach a
consensus [see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed January 2020)].
We summarised debates on a Microsoft Excel® worksheet (Microsoft Corporation, Redmond, WA, USA)
to assess the pros and cons of each design decision. Decisions were made by the research team on the
basis of congruence with the intervention aims, practicality and/or resources needed (for intervention
development or for future maintenance). User views were sought for website design and content once
draft ideas had been conceptualised.
Clinical content of the website
Information about individual contraceptive methods derives from guidelines produced by the UK
Faculty of Sexual and Reproductive Healthcare27 and textbooks.22,28 The website authors (Julia V Bailey
and Lisa Walton) are sexual health professionals who have extensive experience of prescribing
contraception and addressing women’s concerns and queries in clinic settings.
Website development process
We recruited a software company, Moore-Wilson (Salisbury, UK), following a competitive tendering
process. Moore-Wilson drew up website design ideas (wireframes) following team discussions about
possible options. Front-running designs were discussed and refined by women in focus groups run
by Anasztazia Gubijer, with design and content also discussed via an e-mail user group. Website
content was written by Julia V Bailey and Lisa Walton first in Microsoft Word documents (Microsoft
Corporation, Redmond, WA, USA) and/or directly into the website content management system.
For each content feature, there were several design iterations involving the software company,
the research team and target users.
For the video section, we sought freely available YouTube videos that provided accurate information
about different contraception methods. We did not find suitable videos for every method, or for all
of women’s main concerns, so we shot our own films in a digital media studio. We filmed individual
interviews with six young women who described their own experiences of using contraception.
Julia V Bailey then noted the exact time codes for each topic discussed (i.e. specific benefit or problem
with a method). Selected interview excerpts were then played back to clinicians who were filmed
responding to each concern with advice from their clinical experience.
A scoring algorithm was developed by Julia V Bailey for the ‘What’s right for me?’ decision aid, based
on evidence of the likelihood of experiencing a particular effect or side effect with each contraception
method, in terms of amenorrhoea or regular periods, lighter or less painful periods, impact on acne or
premenstrual syndrome, effort involved in remembering a method, presence of hormones and immediate
reversibility. If methods scored exactly the same following women’s choices within the tool, scores were
weighted so that the more effective methods were displayed first.
To see the final Contraception Choices website please visit www.contraceptionchoices.org (accessed
January 2020).
Information on contraceptive methods
The ‘Contraceptive Methods’ section features information on pros and cons of methods presented in
bullet points, with more information available on benefits and side effects, and tips on how to use
each method.
The ‘Effectiveness’ infographic is interactive, displaying the risk of pregnancy for ‘typical use’ of each
contraceptive method and comparing with risk of pregnancy if using no contraception.
The ‘Video’ section features educational YouTube videos and short films of young women expressing
their views and experiences of contraception, followed by clinician explanations on specific topics.
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The ‘Did you Know?’ section addresses women’s most common concerns about contraception.
The ‘Frequently Asked Questions’ section is organised as answers to questions, which show which
methods have specific benefits (e.g. lighter, less painful periods).
Interactive tailored decision aid
The ‘What’s Right for Me?’ tailored decision aid takes into account women’s priorities concerning
contraception attributes and potential benefits to suggest three methods of contraception to suit their
preferences. Hovering over the image of each method offers a very succinct summary of method
attributes, and the tool allows users to see the effect of their choices after each question. For example,
selecting ‘regular periods’ highlights the methods that are compatible with regular periods and fades
out the methods that can alter the menstrual cycle. The top three results are presented side by side,
allowing comparison of the main contraception attributes. If a suggested method is ‘binned’, the next
in the list will be displayed. Results can be exported by e-mail or by text message if a user wishes.
Further information section
Under the tab ‘COVID-19’, the Contraception Choices website features links to several other websites,
such as Find a Sexual Health Service on the NHS website [www.nhs.uk/service-search/other-services/
Sexual-health-information-and-support/LocationSearch/734 (accessed 18 June 2020)].
Additional evaluation of Contraception Choices
In parallel with the Phase II study, a further formative evaluation of Contraception Choices was conducted
by a Master of Science (MSc) student, Xia Zhou, who was studying human–computer interaction. This
study showed that Contraception Choices compared favourably (on qualitative measures) with other
web-based tools that support contraception decision-making and highlighted a few areas in which the
interaction design could potentially be improved. However, as this was a small-scale study, the findings
need further validation, which was outside the scope of this project. See https://uclic.ucl.ac.uk/content/
2-study/4-current-taught-course/1-distinction-projects/1-17/zhou_xia_2017.pdf (accessed 18 June 2020)
[see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed January 2020)].
The findings from the following sources of evidence therefore informed the Contraception Choices
website content (Table 1):
l systematic literature reviews
l women’s priorities and concerns (YouTube study and qualitative fieldwork)
l user design preferences
l clinical evidence and guidelines: UK Medical Eligibility Criteria for Contraceptive Use (www.fsrh.org/
ukmec/) and Faculty of Sexual and Reproductive Healthcare clinical guidelines (www.fsrh.org/
standards-and-guidance/current-clinical-guidance/)
l clinical expertise.
TABLE 1 Rationale for Contraception Choices website content
Issue to address Website section or feature Intended outcome
Need for accurate, balanced
information on contraceptive method
choices; concerns about side effects
or harms; myths and misperceptions
Clearly presented information on
12 contraception methods, explaining




Accurate knowledge to support
informed choice
Less worry about potential side
effects or harms
Inaccurate perceptions of the
effectiveness of different
contraceptive methods
Interactive infographic showing the
likelihood of pregnancy with each
method [URL: www.contraceptionchoices.
org/infographic (accessed January 2020)]
Accurate portrayal of risk of
pregnancy in a form that people
can understand, to support
informed choice
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TABLE 1 Rationale for Contraception Choices website content (continued )
Issue to address Website section or feature Intended outcome
There are many contraception
methods and it is difficult to retain
comparative information
‘Compare all’ contraception methods table
with extra explanation on hovering [URL:
www.contraceptionchoices.org/whats-
right-for-me/table (accessed January 2020)]
Better ability to assess pros and
cons of methods, to support
informed choice by allowing easy
comparison of method attributes
Peer views and experiences
influence women’s contraception
choices. Many women seek peer
views online. Women have mixed
experiences and trust in clinicians
Videos featuring young women and
clinicians: personal experiences of young
women who had used a variety of
contraceptive methods; health-care
professional responses to women’s
concerns within the same video
To acknowledge women’s concerns
through voices they trust (peers
and clinicians) and to show how
concerns might be addressed. Less
worry about potential side effects
or harms
Little knowledge or faith in the
potential benefits of contraception.
Disproportionate worry about side
effects or harms
‘Did you Know?’ [URL: www.
contraceptionchoices.org/did-you-know
(accessed January 2020)] and ‘Frequently
Asked Questions’ [URL: www.
contraceptionchoices.org/faqs (accessed
January 2020)] sections. Honest
information regarding benefits and
concerns about contraception, to
acknowledge and address women’s
concerns and to showcase benefits of
different methods
Accurate knowledge. Less worry
about potential side effects
or harms
Choosing and using contraception
can be complex and difficult, and can
be out of women’s immediate control
‘Challenges’ infographic [URL: www.
contraceptionchoices.org/did-you-know/
challenges (accessed January 2020)] and




Infographics that acknowledge key
factors that influence contraception
choice and use: women’s priorities,
method attributes, partner influence,
friends, family, media, culture and
experience in clinics
Acknowledging that choosing and
using contraception can be difficult.
To draw attention to wider factors
that may be influencing women’s
decisions
Half-hearted use or non-use of
contraception (through lack of access
to informed choice)
What’s Right for Me? decision tool.
Tailored decision aid, for users to
input their preferences in terms of
contraception attributes. Three ‘best-fit’
options are offered and compared side
by side
Decision-aid to simplify the complex
process of weighing up multiple
pros and cons, offering information
that is personally relevant.
Increased motivation to seek a
more suitable method
To provide a personalised record of
contraception choice suggestions
Top three contraceptive method
suggestions. Three top choices of method
compared side by side and e-mailed or
texted, if wanted
To facilitate recall of choices, and
as a prompt for more informed
discussions with clinicians
Most contraception methods need to
be prescribed or fitted by clinicians
Clinic finder. Information on abortion
services and support for domestic abuse
To support the next steps in
acquiring a contraceptive method
(i.e. clinic attendance). Resources for
women seeking abortion or support
with intimate partner abuse
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Chapter 3 Phase II: evaluation trial of
the website
Methods
Original feasibility trial design (objectives 5 and 6)
This was an individually randomised, parallel-group trial.
Setting
Study sites were recruited to represent the health-care settings that provide the great majority of
contraceptive care in the UK (Table 2).
Inclusion criteria
Women were included if they were aged 15–30 years with a need for current or future contraception,
were attending one of the study sites, were able to read English, and had an active e-mail account and
access to the internet.
Exclusion criteria
Women were excluded if they were unable to provide informed consent (e.g. severe learning difficulties)
or if they needed a language advocate to understand English, as the intervention content was intended
to be accessed in private.
The intervention
At the end of Phase I, using evidence from systematic reviews, women’s views on social media, an
expert workshop, and interviews with women and health professionals, we had created a trial-ready,
self-guided website that presents a number of contraceptive options in response to input of women’s
preferences and concerns. The website has four main components: (1) general information on contraception
TABLE 2 Study sites
Category Name Details
Sexual and reproductive health
service
MPC Capper Street, London, UK
Sexual and reproductive health
service for young people
Brook Brook clinic, Euston, London, UK
Abortion service BPAS Romford Road, Stratford, London, UK
Community pharmacy Green Light Pharmacy (Shepherd’s Bush) Uxbridge Road, London, UK
Maternity service Ashford and St Peter’s Hospitals NHS
Foundation Trusta
St Peter’s Hospital, Guildford Road,
Chertsey, Surrey, UK
General practice General practice (Camden and Islington) Clerkenwell Medical Practice,
Finsbury Health Centre, Pine Street,
London, UK
BPAS, British Pregnancy Advisory Service.
a We originally recruited the maternity service at University College London Hospitals NHS Foundation Trust, but
on finding that relatively few women under the age of 30 years attend this service, we switched to Ashford and
St Peter’s Hospital, as this serves a younger pregnant population.
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and method-specific information, including contraceptive benefits, side effects and other common concerns;
(2) an interactive tool to help women choose a method of contraception, which provides individually tailored
results; (3) videos of women and health professionals discussing contraceptive experiences, concerns and
misperceptions; and (4) a page offering a link to NHS clinic finders and other useful resources, such as
further information on sexual health, and websites offering support and advice about sexual abuse.
Outcome measures
Primary outcome
l Follow-up rate at 6 months.
Secondary outcomes: quantitative
l Recruitment rate. Measured via the trial website as the time taken to recruit (up to 80) women at
each site.
l Effectiveness of contraceptive method in use at 6 months. Measured by response to study outcome
questionnaire and grouped as follows: from least to most effective; no method; withdrawal or
natural method; condoms or diaphragm; pill, patch or ring; LARC or sterilisation.
l Change in method between baseline and 6 months, indicating whether any change is to a method of
greater, lesser or similar effectiveness (based on grouping above).
l Pregnancy by 6 months. Measured at 3 and 6 months by response to study outcome questionnaire.
l Sexually transmitted infection diagnosis by 6 months. Measured at 3 and 6 months by response to
study outcome questionnaire.
l Health service and out-of-pocket costs for contraception and other sexual health services.
Measured at 3 and 6 months by response to study outcome questionnaire.
Secondary outcomes: qualitative
l Patient views and experience of the intervention and trial procedures, assessed through qualitative
interviews at 2 weeks after randomisation with five women at each study site (total 25 interviews
[see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed January 2020)]. The
questions explored included:
¢ Are the online trial procedures acceptable to participants? For example, the process of online
registration and consent, the receipt of incentives, completing online questionnaires, contact and
follow-up by e-mail and text?
¢ What are women’s views of the intervention?
¢ How might trial procedures be improved to optimise retention in a full-scale trial?
l Provider views about impacts on the service and trial procedures, assessed through qualitative
interviews with up to 15 key staff (up to three per site), sampling those who have roles in
facilitating the study in each setting (e.g. receptionists, practice managers, nurses, midwives, doctors
and pharmacists) [see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed January
2020)]. The areas explored included:
¢ Are recruitment procedures acceptable to staff?
¢ How might recruitment procedures be improved to optimise recruitment to a full-scale trial?
¢ Staff views on the feasibility and usefulness of a contraception decision website in each
clinic setting?
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Sample size
The original target sample size of 80 participants in each of the settings was based on estimating
an expected follow-up rate at 6 months (primary outcome) of 70%, to within 10% precision [95%
confidence interval (CI) 60% to 80%], for each setting. This sample size also provided 80% power to
detect a statistically significant difference (at the 5% level) in the follow-up rate between two settings
if the true difference is 22% (e.g. 59% vs. 81%). By pooling data across settings, this sample size would
also provide 80% power to detect a statistically significant difference (at the 5% level) in the follow-up
rate between the intervention and standard arms if the true difference is 15% (e.g. 62.5% vs. 77.5%).
The expected follow-up rate was based on a previous sexual health study that recruited and followed
up the participants online (Sexunzipped29).
Baseline survey
Participants were asked to complete a short questionnaire at baseline before randomisation [see
www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed January 2020)]. This included:
l demographic data (age, ethnicity, highest completed level of education) and whether or not English
was their first language
l current use of contraception, or reasons for non-use, including being pregnant, type of method
[see www.journalslibrary.nihr.ac.uk/programmes/hta/137909/#/ (accessed January 2020)], from
where the method was obtained, including whether or not obtained online and if paid for
l satisfaction with current contraception (very satisfied, satisfied, neither satisfied nor dissatisfied,
dissatisfied and very dissatisfied)
l if ever used different methods (same list as current use)
l diagnosed sexually transmitted infections in the last 3 months [see www.journalslibrary.nihr.ac.uk/
programmes/hta/137909/#/ (accessed January 2020)].
Follow-up surveys
At follow-up, at 3 and 6 months, participants were asked what method of contraception they were
using (including none) and how satisfied they were with the method; whether or not they had had
a pregnancy and, if so, the outcome of the pregnancy (ongoing, gave birth, miscarried, terminated,
or prefer not to say); and if they had a diagnosed sexually transmitted infection.
All participants were asked whether or not they had visited the website (control participants were
asked to assess ‘contamination’) and if being in the study had resulted any good or bad effects on
their life.
Intervention group participants only were asked how helpful the website was for getting useful
information about contraception and how helpful it was for finding a method of contraception that is
right for them; whether or not they had discussed the website with anyone, including a doctor or
nurse, pharmacist, partner, family or friends; and what they liked or disliked about the website.
Procedures: recruitment in clinics
Recruitment, completion of the baseline survey and randomisation were all accomplished online using
bespoke trial software, but the process was initiated while the participant was attending one of the
study clinics. Participants randomised to the intervention group were immediately given access to the
website, whereas women randomised to the control group were thanked for their participation and
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then received standard contraceptive care only. All women in both intervention and control groups
were asked by automated e-mail to complete the same outcome questionnaires online at 3 and
6 months. The control group was offered access to the intervention website at the end of the study
(after 6 months’ follow-up).
On arrival at each study site, women were given a flyer about the trial by the reception or research
staff with very brief information about the study, indicating the inclusion criteria. The same information
was available on posters in waiting rooms and clinic rooms [see www.journalslibrary.nihr.ac.uk/
programmes/hta/137909/#/ (accessed January 2020)]. Clinic staff were asked to direct women
who were interested in the study to a member of research staff or directly to the tablet device.
In the feasibility trial, the website was displayed on a tablet computer as it was designed to be available in
clinic and integrated into the clinic pathway, as well as being accessible online at any time. It is accessible
on mobile phones as well as desktop computers. The trial software was set up to allow participants to
go through the steps of screening, consent, automatic randomisation, data collection and intervention
viewing without assistance from the staff, although in practice this process was nearly always guided by
the researcher. We did not use individual identifications or passwords, as recruitment in a previous study
of sexual health websites had been hampered by enrolment procedures that patients found onerous and
time-consuming. Consequently, we streamlined the online trial software as much as possible and minimised
the number of questions asked at baseline and follow-up [see www.journalslibrary.nihr.ac.uk/programmes/
hta/137909/#/ (accessed January 2020)].
Participants who agreed to participate gave their contact details (compulsory e-mail address and
optional telephone number and postal address) for follow-up surveys. They were given electronic
vouchers for completing follow-up surveys (£5 for the survey at 3 months and £15 for the survey at
6 months). All follow-up e-mails included a link to allow participants to withdraw from the study,
including one sent immediately after enrolment.
Randomisation procedures
A randomisation list was generated by a random number-based algorithm in the computer software
Stata® (StataCorp LP, College Station, TX, USA) and incorporated into the trial software program to
allocate all participants to either the intervention group or the control group. The randomisation list
was stratified by setting and using varying block sizes. Allocation was immediate (online) and concealed.
Participants allocated to the intervention condition were directed straight away to the Contraception
Choices website. Those allocated to the control condition were notified that they had not been selected
to view the website until the end of the trial. All participants were reminded that they would be contacted
again in 3 and 6 months to gather follow-up data.
Follow-up procedures
As described in Figure 1, follow-up was automated through e-mail and text messages. If there was no
response to e-mails or texts, the researcher telephoned participants to remind them to complete the
follow-up surveys:
l automated e-mail, with three further follow-up e-mails at weekly intervals
l two text messages (if mobile phone number supplied) at the same time as the last two e-mails
l three telephone calls (if mobile phone number supplied) in 1-week intervals after the final e-mail.
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Study timeline
The planned duration of the feasibility trial was 15 months [see www.journalslibrary.nihr.ac.uk/
programmes/hta/137909/#/ (accessed January 2020)]:
l 6 months’ recruitment (based on the large number of patients attending each of the study sites,
and an estimated proportion of 20–30% agreeing to take part, given previous experience of similar
studies and the financial incentives offered)
l 6 months’ follow-up
l 3 months’ analysis of quantitative and qualitative data.
Baseline completed
E-mail at 3 months
3-month survey
completed
No response at 
3 months
E-mail at 6 months
6-month survey
completed 
No response at 
6 months 
• Three follow-up
    e-mails at
    weekly intervals
• Text messages with
    the web link
• Telephone call
    reminders
• Postal follow-up
Lost to follow-upLost to follow-up
• Three follow-up
    e-mails at
    weekly intervals
• Text messages with
    the web link
• Telephone call











    e-mails at
    weekly intervals
• Text messages with
    the web link
• Telephone call
    reminders
Lost to follow-up
FIGURE 1 Follow-up procedures in feasibility trial.
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Phase I took longer than anticipated, largely because of the lengthy process of obtaining research
permissions. During Phase II, we were awarded a 6-month no-cost extension when the feasibility trial
changed to an efficacy trial.
Trial process evaluation
In addition to obtaining women’s views on the website itself, we assessed women’s experiences of
taking part in an online study of contraception. This formed an early part of the feasibility study and
the findings were intended to inform the subsequent feasibility trial.
Aim
To explore women’s experiences of taking part in an online study of a contraception website and to
use the information to improve the subsequent trial design as appropriate.
Methods (trial procedures, rapid follow-up, then interviews)
We recruited 18 women from all the clinic sites to take part in an ‘expedited’ study of the website,
followed by an interview to explore their experiences. Unlike the subsequent recruits, who were
randomised to the intervention or control group, all of the early participants were assigned to the
Contraception Choices website and followed up by e-mail 1 week after recruitment, rather than 3 and
6 months later. This method enabled us to gain information about the website and the trial procedures
in a short time, so that we could make any necessary changes before starting the main recruitment.
It also meant that participants had a shorter time period over which to recall their experiences, which
should enhance the reliability of their recollections. As these early participants were not randomly
allocated to the intervention or control group, they were not included in the randomised trial.
Findings
The main reason for agreeing to take part was an interest in finding out more about contraception.
Participants found registering for the study on the tablet computer ‘quick’ and ‘easy’ and the information
provided ‘clearly written’ so that they understood what the study was about and what they were
agreeing to. Most participants felt that it was appropriate and acceptable to be approached about
the study in a clinic waiting room.When asked what they felt about the topic of contraception and
pregnancy, women commented that they were:
Open to it . . . like being in the clinic anyway, you kind of expect to, to talk about it . . . it’s quite
comfortable . . . it wasn’t really that weird to talk about it.
One participant recruited from the abortion service felt ‘mixed’ about being asked about contraception
and pregnancy at the time:
I don’t really know I think I was quite mixed there because I was definitely like not, well I guess I was just
like cursing myself at the time I was like this is something I should have thought about before.
In general, participants did not have concerns about providing their contact details (telephone number
and e-mail address) and understood that they were giving them so the research team could send them
the follow-up questionnaire and contact them to arrange an interview. Once recruited, participants
found it convenient to be contacted about the study by e-mail, text and telephone.
All participants, when asked, reported that they would take part in the study again.
Conclusions for the trial
Given the overall positive findings from these early recruits, we concluded that there was no need to
make changes to the feasibility trial design.
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Transition from feasibility to efficacy trial (modified objective 7)
As noted above, the immediate popularity of the Contraception Choices website with young women
and contraception providers convinced us to ‘expand’ the feasibility trial into an efficacy trial. To
achieve this, we increased the recruitment target and changed the primary outcome from a feasibility
measure (6-month follow-up rate) to clinical outcomes that were originally secondary outcomes in the
feasibility trial, resulting in two primary outcomes: (1) use of LARC at 6 months and (2) satisfaction
with contraceptive method at 6 months.
In addition to the 400 women recruited to the feasibility trial, we planned to recruit another 530 women
from one site only, the MPC, via its routine online booking system.We estimated that a total of
930 participants would be sufficient to detect an (82% power) increase in uptake of long-acting methods
from 35% to 47%, assuming a follow-up rate of 70%. No formal calculation was made for the other
primary outcome – satisfaction with method.
When women request an appointment for contraception at MPC, they are routinely directed to the
trust website to book their appointment. Once an appointment is booked, the patient receives a text
message confirming the date and time of their appointment. For the efficacy trial, we inserted into the
routine text an invitation to take part in contraception research by clicking on a hyperlink. Clicking on
the hyperlink took women to the trial recruitment home page from where all procedures were the
same as those described above.
Statistical analysis
For the efficacy trial, the analysis focused on the effect size for the key clinical outcomes that became
primary outcomes: use of a LARC method at 6 months and satisfaction with contraceptive method at
6 months.
The primary analysis is by modified intention to treat, basing analysis on those who complete at least
one follow-up outcome questionnaire. For each outcome listed above, we present the percentage of
participants if the outcome is binary (e.g. use of LARC) or ordinal (e.g. effectiveness of method,
satisfaction with method) together with a 95% CI. These percentages and means are reported
separately by intervention and standard care arm.
To formally assess differences between arms, we use logistic regression (for binary outcomes) or
ordinal logistic regression (for ordinal outcomes), reporting adjusted odds ratios (ORs) with 95% CIs.
The primary outcome of LARC use at 6 months is analysed among women in need of contraception
(not pregnant or currently trying to become pregnant) and the primary outcome of satisfaction with
method is analysed among women who are using a method at 6 months. The primary outcome of LARC
use at 6 months is analysed stratified by LARC use at baseline, leading to three intervention effects:
(1) the effect in baseline LARC users, (2) the effect in baseline non-users and (3) the overall effect
adjusted for baseline LARC use. Assuming that < 90% of baseline LARC users in the control arm are
using a LARC method at 6 months, the primary effect measure is the overall adjusted intervention
effect. If, conversely, > 90% of baseline LARC users in the control arm are using a LARC method at
6 months, the primary effect measure is the intervention effect in women not using a LARC method at
baseline, because there would be little possibility of increasing LARC use through the intervention in
baseline LARC users. Besides adjustment for baseline LARC use, analysis of both primary outcomes is
also adjusted for satisfaction with method at baseline and setting. A further subgroup analysis is also
presented for both primary outcomes to assess, based on testing an interaction term, whether or not
the effect of the intervention varies by setting.
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Primary comparisons for the primary outcomes between arms are based on multiple imputation, for
which the primary outcomes at 6 months are imputed based on the outcomes at 3 months for those
participants who completed the 3-month outcome questionnaire but failed to complete the questionnaire
at 6 months. Imputation was conducted using the chained equations approach and implemented using the
mi impute function in Stata; 20 imputed data sets were generated.
A post hoc decision was made to conduct a ‘per-protocol’ analysis for the primary outcomes based on a
comparison of intervention arm participants who reported seeing the Contraception Choices website
with all control arm participants.
Costs of contraception and budget impact analysis
The primary analysis is a budget impact analysis of the website and contraception reporting the total
costs to each payer [NHS (primary care vs. secondary care), local government, private and out of
pocket]. This will be reported as the total cost of contraception and pregnancy outcomes for a range of
different population sizes. The analysis conforms to the International Society for Pharmacoeconomics
and Outcomes Research (ISPOR) good practice guidelines for budget impact analysis.30
Costs include the cost of contraception (NHS and out-of-pocket costs), including the cost of LARC,
sexual health service use, sexual health-related primary and acute care use, and the cost of pregnancy-
related outcomes. Resource use collected as part of the trial is costed based on published sources
including Personal Social Services Research Unit (PSSRU) reference costs31 and the British National
Formulary.32 Details for unit costs are reported in Table 3. For contraception, when there is more than
one option, for example the different types of the combined pill, the lowest-cost option of (1) the option
recommended by the NHS or, if not available, (2) the most commonly taken was used to determine the
cost used. Out-of-pocket costs are costed at the same value as publicly financed costs except in the
case of condoms, in which case it is assumed that three are given out by the NHS or other community
sexual health services, but that people buy a pack of 24 if bought out of pocket. All costs are reported
in 2016/17 Great British pounds.
At 6 months, participants were asked if they had become pregnant in the past 6 months and the
outcome of the pregnancy. The cost of termination is costed as the weighted costs for all terminations
in the NHS (£840 reference costs). The cost per miscarriage and cost per full-term pregnancy were
taken from Public Health England33 contraception return on investment analysis at £653 and £5735
per pregnancy, respectively.
The cost of the website includes ongoing maintenance costs and how these might be incurred by
organisations that wish to use the website in the future. This cost is reported for a range of different
population sizes.
In addition to the budget impact analysis of total cost for each payer, we report descriptive statistics
for each cost type. We calculated the average total health-care cost of contraception per participant
for the website compared with current practice at baseline and 6 months. The 95% CIs for each
analysis are reported based on linear regression adjusting for baseline and site and bootstrapping
with bias-corrected adjustment.
As there is limited information available on the number of free condoms that women obtain from the
NHS every 3 months, we assumed cost containment and the minimum number per pack (three
condoms). We have included a sensitivity analysis in which this number is increased to 12 every
3 months, the number available on a condom card, at a cost of £9.99 every 3 months.
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Ethics issues
In describing the ethical issues to the Research Ethics Committee, we included the following points:
l We did not foresee major ethical issues or risks associated with asking individual participants or
groups of women (focus group discussions) about access, acceptability and adherence to different
methods of contraception, or the likely features of an IDI that might help them make better
contraceptive choices. Nonetheless, all interviews and focus groups were facilitated in a sensitive
manner by experienced researchers, setting out ground rules at the start for mutual respect and
non-judgemental stances about lifestyle or behaviour choices.
l It is important to include women aged 15 years, as around one-fifth to one-third of women have had
sexual intercourse before the age of 16 years and the intention was to help inform young women’s
first thoughts and choices about contraception. A substantial proportion of women attending
community pharmacy and specialist contraceptive services, in particular, are aged 15 years.
l We assessed capacity to consent to the research by offering written study information and by
answering any queries about the research. Young women wishing to discuss this with parents or
others first were encouraged to do so. We did not require parental consent, as young women may
be excluded from the research if parental consent was required.
The study was approved by London – Camden & King’s Cross Research Ethics Committee and by the
Health Research Authority, including substantial amendments (reference 17/LO/0112).
TABLE 3 Cost of contraception-related resource use
Resource
Unit cost (for 3 months
for medication) (£) Reference
General practice 31.00 PSSRU31
Sexual health clinic 121.12 Reference costs34
Young persons’ clinic (assume NHS band 5 nurse) 12.00 PSSRU31
Pharmacy 8.80 PSNC35
Gynaecology 140.93 Reference costs34
Combined or unknown pill [ethinylestradiol with norgestimate (Cilest)] 7.16 BNF32
Mini pill [desogestrel (Cerazette)] 2.75 BNF32
Contraceptive patch [ethinylestradiol with norelgestromin (EVRA)] 19.51 BNF32
Vaginal ring [ethinylestradiol with etonogestrel (NuvaRing)] 29.70 BNF32
Pack of condoms (24 pack) 11.99 Boots36
Condoms (three free per 3 months) 2.29 Boots36
Female condoms (pack of five) 5.99 Amazon37
Emergency contraception [ulipristal acetate (EllaOne)] 14.05 BNF32
Diaphragm 10.21 BNF32
Injectable contraception [medroxyprogesterone acetate (Provera)] 6.01 BNF32
Implant [etonogestrel (Nexplanon)] 83.43 BNF32
Intrauterine system [levonorgestrel (Mirena)] 83.43 BNF32
Intrauterine device: copper 8.95 BNF32
Vasectomy 829.57 Reference costs34
Female sterilisation 2416.00 Reference costs34
BNF, British National Formulary; PSNC, Pharmaceutical Services Negotiating Committee.
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Chapter 4 Trial results
Recruitment
The first participant was randomised on 4 July 2017 and the last on 22 December 2017.
The first recruitment through the MPC online central booking service was on 31 October 2017 and
the last on 22 December 2017.
Recruitment online was much faster than in the clinics. It took approximately 6 months to recruit
400 women from the clinic sites, as originally planned; we recruited 530 women via the online booking
system in just over 7 weeks.
Follow-up
The last follow-up survey was completed on 16 August 2018.
The Consolidated Standards of Reporting Trials (CONSORT) flow diagram (Figure 2) details the flow of
participants through the trial.
In total, 927 women were randomised to the website (n = 464) or to the control group (n = 463),
of whom 739 (80%) provided follow-up data at 6 months and 786 (86%) provided data at 3 and/or
6 months for analysis of primary outcomes with imputation.
Follow-up rates were similar across all sites (data not shown), except the British Pregnancy Advisory
Service (BPAS), for which the follow-up rate was only 50%. Women often gave incorrect contact details
that prevented follow-up.
The quality of the survey data collected was exceptionally high, with nearly 100% of women
responding to the follow-up questionnaires providing the primary outcome data.
A total of 19 women (2%) withdrew from the trial: 11 from the intervention group and 7 from the
control group. They did not offer reasons for withdrawing.
Qualitative findings
Over four-fifths of participants in the intervention group provided free-text comments in the follow-up
surveys at 3 and 6 months. All free-text comments were coded and analysed using thematic analysis.
Comments about the website were overwhelmingly positive, with a few neutral comments from
women who were already well informed. The only negative comments were from women with medical
conditions, such as polycystic ovary syndrome, who did not find information specific to their condition.
The following themes and subthemes emerged.
Information/website content
Evidenced-based and trustworthy information
As a trainee GP myself I would definitely sign post people to this website in the future when
discussing contraception.
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Increased knowledge and awareness about contraception
I feel very well educated thanks to the website – I wish someone had explained about all the different
choices years ago.
Honest information about pros and cons
It’s nice to get an overview of all contraception options out there, the pros and cons, so you can review
them in your own time.
Tailored information
This website ensures girls can get the best contraception for THEM and only them.
Informative after having a baby
I have just had a baby, however, in the next few months I believe that I will be looking at contraception









































































Total number of intervention participants with
3- or 6-month follow-up completed
(n = 388)
Total number of control participants with
3- or 6-month follow-up completed
(n = 398)
FIGURE 2 Consolidated Standards of Reporting Trials (CONSORT) flow diagram. Reproduced with permission from
Stephenson et al.38 This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://
creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further
permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.
com/en-us/nam/open-access-at-sage). The figure includes minor additions and formatting changes to the original text.
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Website improvement suggestions
I wish it had more tips on dealing with difficult conversations that can happen or knowing your rights
(like what to do if your GP won’t allow you to have the method you want, or tries to convince you that
one type is better because it’s cheaper) [sic].
Design and format
Visual aesthetics
The interface is easy to use and aesthetically pleasing.
User-friendly
I love the simplicity of the website. It’s easy to find the method of contraception you’re interested in.
It’s informative and it’s very quick finding what you need.
Easy to understand
The language is clear and simple, which is very helpful when English is not your first language.
Accessible at any time
I like that I can research safe and comfortable with reliable information from my own home.
Health professional interaction
Women felt more empowered to speak to their health professionals
It has made me feel more confident. Prior I didn’t really have anyone to speak to about contraception and
I didn’t feel comfortable discussing it with my doctors so this bridged the gap.
Aiding appointments
[Using the website at home meant] more time to consider options without feeling pressure to pick
something that might not be the best option.
Reported impacts of the Contraception Choices website
Changing or considering swapping to a new contraceptive method
I think it’s [the website] got me thinking more about which contraception I should use. I’m quite happy
with my pill and currently not sexually active, but I do think I would like to switch to a LARC if I am in a
relationship again.
Changing behaviour due to having misperceptions addressed
It’s cleared up some of my doubts and things I worried about (probably unconsciously!) about
hormonal contraception.
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Reminders to act
If anything the e-mails have been a helpful reminder to sort a more permanent solution for my
contraception needs.
Discussing the website with others
It’s [the website] helped me be more open about contraception and discuss it with friends. It’s become less
of a taboo.
Health service barriers to accessing contraception
Lack of appointments/long waiting times
Long waiting times. GP did not offer the services to get implant fitted. Lack of sexual health clinics in my
area means very long waiting times.
Lack of services offering long-acting contraception methods
Very difficult to find an appointment to have an implant replaced due to GPs no longer offering this
service. Spent 2 full days off work waiting in clinics but was not seen. Implant was 1 month out of date
before I was able to book an appointment.
I wanted the coil but I found it difficult to find someone to fit it in London.
Being part of the study
I feel I’m part of a community of (mainly) women who are talking about sexual health openly. I wish I had
seen studies like this when I was younger and just beginning to be sexually active, as I wouldn’t have felt
as scared or alone as I did.
Quantitative findings
The baseline characteristics by study arm (Table 4) show that 419 women were recruited in clinics and
508 women were recruited via the MPC online booking system. Recruitment within clinics was highest
for the MPC and lowest in BPAS.
TABLE 4 Baseline characteristics by study arm
Characteristic Intervention (N= 464), % (n) Control (N= 463), % (n)
Site of recruitment
MPC 8.6 (40) 8.4 (39)
Clerkenwell 7.3 (34) 8.2 (38)
BPAS 4.5 (21) 4.8 (22)
Ashford 8.4 (39) 8.6 (40)
Green Light 6.9 (32) 7.1 (33)
Brook 8.8 (41) 8.6 (40)
Central booking 55.4 (257) 54.2 (251)
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TABLE 4 Baseline characteristics by study arm (continued )
Characteristic Intervention (N= 464), % (n) Control (N= 463), % (n)
Demographic factor
Age (years), median (IQR) 24 (21–27) 24 (21–27)
Ethnicity
White 67.0 (306) 71.0 (326)
Mixed 11.6 (53) 10.5 (48)
Asian 10.3 (47) 8.1 (37)
Black 9.0 (41) 8.3 (38)
Other 2.2 (10) 2.2 (10)
First language
English 80.8 (375) 84.2 (390)
Not English 19.2 (89) 15.8 (73)
Highest completed level of education
Degree 51.3 (238) 49.9 (231)
Diploma in higher education 10.6 (49) 9.7 (45)
A level/AS level 21.3 (99) 23.5 (109)
O level/GCSE 9.7 (45) 7.8 (36)
Other 5.4 (25) 5.8 (27)
None 1.7 (8) 3.2 (15)
Contraception factor
Need for contraception
No: pregnant 9.7 (45) 10.6 (49)
No: trying for baby 0.2 (1) 0.2 (1)
Yes: neither 90.1 (418) 89.2 (413)
Method used, if needed, ordered by efficacy
None 17.7 (74) 18.6 (77)
Unclear 0.2 (1) 0.5 (2)
Withdrawal/natural 0 (0) 1.2 (5)
Condom/diaphragm 10.5 (44) 11.1 (46)
Pill/patch/ring 42.6 (178) 39.0 (161)
LARC/sterilisation 29.0 (121) 29.5 (122)
Satisfaction with method, if using a method
Very dissatisfied 4.3 (15) 3.3 (11)
Dissatisfied 11.6 (40) 12.2 (41)
Neutral 16.2 (56) 17.2 (58)
Satisfied 36.4 (126) 32.6 (110)
Very satisfied 31.5 (109) 34.7 (117)
A level, Advanced level; AS level, Advanced subsidiary level; GCSE, General Certificate of Secondary Education;
IQR, interquartile range; O level, Ordinary level.
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Just over two-thirds of participants were from white ethnic groups, half were educated to degree level
and four-fifths reported English as their first language.
Ten per cent were pregnant, with the remaining 90% indicating a current need for contraception to
avoid unintended pregnancy. The most common method was the pill, followed by LARC methods.
Around two-thirds of women were satisfied with their current method at baseline.
Of the 364 intervention participants with 6-month follow-up data, 309 (85%) reported seeing the
Contraception Choices website. Of those, 97% found it helpful or very helpful for ‘getting useful
information about contraception’ and 87% responded that it was helpful or very helpful for ‘finding a
method of contraception that is right for you’.
Primary outcomes
There was no statistically significant difference between intervention and control groups in the
proportion of women using LARC at 6 months [30.4% intervention vs. 31.0% control, adjusted OR
after imputation 0.87 (95% CI 0.60 to 1.27)], nor in level of satisfaction with contraceptive method
[proportion being ‘satisfied’ or ‘very satisfied’, 82.6% intervention vs. 82.1% control, adjusted ordinal
OR 0.93 (95% CI 0.69 to 1.26)] based on the five ordered responses (Table 5).












LARC method in use at
6 months, overall (N = 713)a
30.4 (106) 31.0 (113) p = 0.88
0.97 (0.71 to 1.35)
p = 0.62
0.91 (0.61 to 1.33)
After imputation p = 0.74
0.95 (0.69 to 1.30)
p = 0.48
0.87 (0.60 to 1.28)
If using LARC at baseline
(N = 201)
58.8 (57) 70.2 (73) p = 0.08
0.59 (0.32 to 1.06)
p = 0.013
0.41 (0.21 to 0.83)
After imputation p = 0.12
0.63 (0.35 to 1.12)
p = 0.024
0.46 (0.23 to 0.90)
If not using LARC at baseline
(N = 512)
19.4 (49) 15.4 (40) p = 0.19
1.37 (0.86 to 2.19)
p = 0.27
1.32 (0.81 to 2.15)
After imputation p = 0.40
1.22 (0.77 to 1.92)
p = 0.49
1.18 (0.74 to 1.90)
Satisfaction with method used at 6 months, (N = 624)b
Very dissatisfied 1.9 (6) 1.6 (5)
Dissatisfied 4.2 (13) 5.8 (18) p = 0.52
0.91 (0.68 to 1.22)
p = 0.65
0.93 (0.69 to 1.26)
Neutral 11.3 (35) 10.5 (33)
Satisfied 39.9 (124) 35.5 (111)
Very satisfied 42.8 (133) 46.7 (146)
After imputation p = 0.54
0.91 (0.68 to 1.22)
p = 0.62
0.93 (0.69 to 1.25)
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Secondary outcomes
There was no difference between groups in the proportion of women who were pregnant at 6 months,
or the proportion with a diagnosed sexually transmitted infection at 3 or 6 months.
Around half of the participants in each group changed their method of contraception between baseline
and 6 months; the most common change was to a more effective method (24% intervention group,
21% control), but 19% in the intervention group and 16% in the control group changed to a less
effective method.
The proportion of women in the intervention group who confirmed that they had seen the Contraception
Choices website was 84.9%, whereas the proportion in the control group was < 7%, indicating good
recognition in the intervention group and little contamination in the control group.
Post hoc per-protocol analysis of the primary outcomes was not appreciably different from the
modified intention-to-treat analysis (Table 6).












Effectiveness of contraceptive method at 6 months (N = 713)a
None 10.9 (38) 14.0 (51)
Withdrawal/natural 1.7 (6) 1.4 (5) p = 0.63
1.07 (0.82 to 1.40)
p = 0.33
1.15 (0.87 to 1.52)
Condom/diaphragm 12.6 (44) 12.1 (44)
Pill/patch/ring 44.4 (155) 41.5 (151)
LARC/sterilisation 30.4 (106) 31.0 (113)
Change in method from baseline to 6 months (N= 651)c
Change to more effective 23.8 (76) 20.5 (68)
Change to similarly effective 11.3 (36) 12.7 (42) N/A N/A
No change 46.3 (148) 51.1 (169)
Change to less effective 18.8 (60) 15.7 (52)
Pregnancy by 6 months
(N = 670)d
3.3 (11) 4.1 (14) p = 0.66
0.86 (0.43 to 1.69)
p = 0.76
0.90 (0.45 to 1.79)
STI diagnosis reported at 3 or
6 months (N = 624)e
5.3 (16) 4.7 (15) p = 0.76
1.12 (0.55 to 2.31)
p = 0.72
1.14 (0.55 to 2.36)
N/A, not applicable; STI, sexually transmitted infection.
a Analysis restricted to not pregnant or trying for baby at 6 months.
b Analysis restricted to using a method at 6 months.
c Analysis restricted to not pregnant or trying for baby at baseline or 6 months; clear reporting of method at both
time points.
d Analysis restricted to not pregnant or trying for baby at baseline.
e Analysis restricted to completed 3- and 6-month questionnaire items.
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Budget impact analysis
The average cost of publicly funded contraception in the Contraception Choices website group over
6 months was £231 [standard error (SE) £9.90; n = 336], and it was £230 (SE £9.80; n = 346) in the
control group. The average cost of pregnancy in the Contraception Choices group was £169 (SE £49.40;
n = 364), and it was £84 (SE £31.30; n = 372) in the control group. The higher cost of pregnancy in the
Contraception Choices group is not due to more pregnancies (see Table 8), but the fact that, among women
who did get pregnant in the Contraception Choices group, and who were not trying for a baby at baseline,
there were fewer terminations [n= 4 (1.0%) vs. n= 6 (1.4%)], although the numbers are very small and
hence for explanatory purposes only. The average out-of-pocket contraception costs over 6 months
were £53 (SE £5.60; n= 336) for the Contraception Choices group and £42 (SE £4.90; n= 346) for
the intervention group.
Based on bias-corrected bootstrapped CIs (1000 iterations) and controlling for baseline cost and
recruitment site, there was no statistically significant difference between the two groups in publicly
funded contraception costs excluding pregnancy (£3.67, 95% CI –£18.17 to £28.56) or including
pregnancy (£73.65, 95% CI –£46.38 to £192.40) or in private out-of-pocket costs (£11.19, 95% CI
–£2.84 to £26.72). In the sensitivity analysis, assuming a higher cost every 3 months for free condoms
from the NHS, the difference between the two groups for publicly funded contraception costs remains
similar (£4.06, 95% CI – £28.87 to £17.87).
Table 7 reports the results of the budget impact assessment by providers. This is calculated as the
average cost per woman for each provider in a given population, assuming that the population
recruited to the trial is broadly representative of the wider population of women accessing
contraception. The total cost was also extrapolated for the 5,128,093 women aged 15–30 years in
England in 201739 and for an average local authority population of 14,000 women aged between 15
and 30 years. Table 8 reports the results by recruiting site. Values are greater in Table 8 as they reflect
the total cost per woman in the study for all contraception use over 6 months (excluding pregnancy
and out-of-pocket costs). For example, of the women recruited through a general practice, 11% also
attended a sexual health clinic.
TABLE 6 Post hoc per-protocol analysis of primary outcomes
Outcome measure
Intervention








LARC method in use at
6 months (N = 660)a
31.4 (93) 31.0 (113) p = 0.86
1.03 (0.74 to 1.44)
p = 0.98
0.99 (0.66 to 1.49)
Satisfaction with method used at 6 months (N= 578)b
Very dissatisfied 1.1 (3) 1.6 (5)
Dissatisfied 4.2 (11) 5.8 (18) p = 0.87
0.97 (0.72 to 1.33)
p = 0.95
1.01 (0.74 to 1.39)
Neutral 10.9 (29) 10.5 (33)
Satisfied 39.3 (104) 35.5 (111)
Very satisfied 44.5 (118) 46.7 (146)
a Analysis restricted to not pregnant or trying for baby at 6 months.
b Analysis restricted to using a method at 6 months.
Reproduced with permission from Stephenson et al.38 This article is distributed under the terms of the Creative
Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction
and distribution of the work without further permission provided the original work is attributed as specified on the
SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). The table includes minor
additions and formatting changes to the original text.
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The 6-month cost of hosting the website is £3021. For the MPC (central booking plus the MPC), which
recruited 587 patients in total, this would be equivalent to £5.15 per patient, similar to the cost savings its
patients achieved as part of the study (see Table 8). For a local authority of 14,000 patients, this works out
to approximately £0.21 per patient and across the whole of England it starts to approach £0 per woman.
Health-related quality of life
Initial qualitative work associated with developing the questionnaires identified that women did not
find a health-related quality-of-life measure (the EuroQol-5 Dimensions) or a condition-specific
measure (Sexual Quality of Life) appropriate for the study. As a result, we did not include either of
these measures as an outcome. However, the initial work was completed as a systematic review of
the quality-of-life measures for contraception and an MSc thesis [see www.journalslibrary.nihr.ac.uk/
programmes/hta/137909/#/ (accessed January 2020)].












General practice 13.18 14.36 –6,051,150 –16,520
Sexual health service 153.57 159.78 –31,845,458 –86,940
Acute health care 0.76 2.22 –7,487,016 –20,440
Acute health care,
including pregnancy costs
160.22 93.05 344,454,007 940,380
Pharmacy costs 0.86 0.75 564,090 1540
Young persons’ clinic 0.09 0.29 –1,025,619 –2800




Choices cost (£) Control cost (£)
Difference per
woman (£)
MPC 277.00 282.61 –5.61
General practice 103.94 192.31 –88.37
Abortion service 145.25 143.09 2.16
Maternity service 13.65 35.30 –21.65
Pharmacy 191.91 147.53 44.38
Brook sexual health service 233.43 124.85 108.59
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We describe here the process and outcomes of designing and evaluating Contraception Choices,an interactive website to aid informed choice of contraception. The evidence base for the
website came from extensive systematic review of published literature, review of social media
(YouTube), empirical qualitative research with young women and expert opinion. The evaluation
method was unusually rigorous for a website; according to recent NICE guidance, a randomised trial is
the standard reserved for those digital health technologies that aim to prevent and manage disease.40
At the outset, we did not expect to complete an efficacy (Phase III) trial of the website, but immediate
demand for Contraception Choices from service providers, who could signpost patients to it through
their own clinic websites, prompted the transition from a feasibility to an efficacy trial. Overall, the
study procedures worked well and were highly efficient: the total project expenditure, or cost to the
funder, for intervention design and evaluation combined was < £754 per participant. Leaving aside
delays in Phase I due to the lengthy process of obtaining all research permissions, the trial processes
worked well: the follow-up rate was good, with 86% of participants providing primary outcome data at
6 months. Even recruitment in clinics was completed within the anticipated 6 months, but recruiting
online (via the MPC online booking system) was much more efficient, being both faster and without
additional cost. Just over half of all participants were recruited in this way in < 8 weeks.
Our study underscores other evidence that online trials are an efficient method of conducting clinical
trials of low-risk interventions, and that such methods are acceptable to participants.18 Other research
suggests that online recruitment methods in trials of online interventions can improve the validity of
the findings.19 In our study, women recruited online had a different experience of being in the trial
to women recruited while attending a clinic or pharmacy, but there were no statistically significant
differences in outcomes by method of recruitment (data not shown).
Given the strikingly positive feedback about the website, from women and health-care providers, the
high level of intervention reach (over four-fifths viewed the website) and low ‘contamination’ in the
control group (only 7% of the control group reported seeing the website), the lack of difference in
primary outcomes between groups was disappointing. The free-text comments appeared to affirm the
purpose of the website and, arguably, the theoretical basis that might lead to efficacy, but this was not
observed in quantitative terms. Possible reasons relate to the many influences on contraceptive use
beyond a woman’s control, as evidenced by our systematic review and reported barriers to accessing
services to obtain a desired method, due to difficulties in getting appointments, long waiting times
and a lack of services that can fit LARC methods. Other possible reasons include a longer follow-up
period needed for intentions stimulated by the website to translate into action; measurement reactivity
(i.e. the possible impact of asking the control group about their contraception use); the limitations of a
broad outcome measure such as ‘satisfaction with method’; and the possibility that both the intervention
group and the control group were receiving high-quality clinical care, so that the website could not show
an additional effect. With hindsight, we might have seen statistically significant differences between
groups had we included intermediate outcomes, such as ‘feeling better informed about choice of methods’
or ‘feeling confident about discussing different contraceptive methods with a health professional’, but,
ultimately, we were interested in increasing the number of women using an effective contraceptive
method through providing information on all available options, their advantages and disadvantages, and
dispelling common myths. The finding, for the subset of women using LARC at baseline, that LARC use at
6 months was lower in the intervention group than in the control group raises the possibility that women
had gained information from the website that led them to choose an alternative method that suited them
better than LARC. Although the data do not allow us to draw firm conclusions about this, we know that
LARC methods, despite being the most effective at preventing pregnancy, do not suit all women and
it would be unhelpful to assume otherwise. In general, though, there was no statistically significant
difference between groups in the proportion of women who changed to a more or less effective method.
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Our systematic review of quality-of-life measures did not identify a suitable measure of quality of life
for women using contraception that would allow us to conduct a cost per quality-adjusted life-year
(QALY) analysis. However, NICE public health methods guidance recognises that cost per QALY may
not always be the most suitable analysis for an economic evaluation in public health interventions.
Cost–consequences analysis, reporting costs alongside effectiveness measures, is sometimes
recommended as a more suitable economic evaluation method.
If the aim of a future trial is to inform NICE guidance, then new NICE digital health intervention guidance
may be the most relevant. The current draft guidance suggests both a cost-per-QALY analysis and a budget
impact analysis. More work is therefore required on developing a suitable preference-based measure in
contraception. If local decision-makers are the key audience, then budget impact analysis or return on
investment, in addition to evidence on clinical effectiveness and safety, may be sufficient, as local decision-
makers are primarily interested in direct financial implications for their services.
Given the increase in sample size and the decision to examine efficacy, we chose, in addition, to look at
statistical significance in costs. There was no statistically significant difference between the two groups
in costs. Pregnancy costs were higher in the intervention groups (although not statistically significantly
so) because more pregnancies were carried to full term and there were fewer terminations in the
Contraception Choices group, rather than more pregnancies in total.
The advantage of the Contraception Choices website as an intervention to provide women with
balanced information to support their choice of contraception method is that the intervention can be
rolled out to a large number of women with no additional cost, as it includes only the fixed cost of
website maintenance and hosting. Consequently, as more women access the website the cost per
woman approaches zero.
In terms of implementing the website in NHS services, the method of directing patients to the
Contraception Choices website via a text message to confirm a clinic appointment booked online
seems a promising way forward. It enables large numbers of women to have access to the website
at the time of planning a contraceptive consultation when they are likely to benefit from a more
informed discussion with a doctor or nurse. It is easy to imagine a woman bringing to her appointment
three contraception options generated by ‘What’s Right for Me?’ on her mobile phone and seeing the
website open on the health professional’s computer screen in the clinic. For this study, we did not aim
to assess such a development in clinical practice, but we hypothesise that it could lead to a more
satisfying consultation for both individuals, with potentially better clinical or service outcomes.
DISCUSSION
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Chapter 6 Conclusions/recommendations
The Contraception Choices website was popular among young women for its design, presentationof trustworthy information and guidance in choosing a method tailored to individual preferences.
It is currently promoted via a link on the NHS website, which receives around 11 million visits per year
[URL: www.nhs.uk/conditions/contraception/which-method-suits-me/ (accessed January 2020)]. However,
it was not associated with any statistically significant difference in use of LARC or satisfaction with
contraceptive method at 6 months. Our systematic reviews confirmed multiple factors affecting women’s
choice and use of contraception that go beyond informed choice, including the influence of partners,
friends, family, school, religion, wider culture and health services.
The availability of the website on the internet offers many possibilities for further use and evaluation.
In our systematic review, we found remarkable consistency across the globe in factors influencing
contraception choice, uptake and use. With appropriate adaptations, Contraception Choices may be of
benefit to populations in different settings (e.g. schools, non-clinic populations) or different countries;
we are currently exploring its utility in Botswana, a country with advanced e-health capacity and high
human immunodeficiency virus prevalence.
The lack of effect on clinical outcomes in this trial, despite highly positive feedback from participants,
highlights a gap between improving delivery of information and impact on contraceptive use. We
hypothesise that this gap can be narrowed by shared reference to the website between patients and
health-care professionals during contraception consultations. Contraception providers are keen to
promote the website. Future research could examine the impact of the website in different settings
(e.g. in schools) or different countries. Specifically, we recommend research to determine whether
or not use of the website during contraceptive consultations improves the quality or efficiency of
consultation for both patients and health-care providers.
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